ダウンロード数: 720

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
62_7_367.pdf726.65 kBAdobe PDF見る/開く
タイトル: 化学放射線療法が奏功した尿道癌の2例―80歳を超える女性症例の経験―
その他のタイトル: Combined Chemotherapy with Radiation was Tolerable and Effective Treatment in Female Octogenarian Patients with Urethral Cancer ―Two Case Reports―
著者: 立花, 貴史  KAKEN_name
松本, 和将  KAKEN_name
名木, 渉人  KAKEN_name
萩原, 正博  KAKEN_name
小林, 健太郎  KAKEN_name
津村, 秀康  KAKEN_name
吉田, 一成  KAKEN_name
岩村, 正嗣  KAKEN_name
著者名の別形: Tachibana, Takashi
Matsumoto, Kazumasa
Nagi, Shoji
Hagiwara, Masahiro
Kobayashi, Kentaro
Tsumura, Hideyasu
Yoshida, Kazunari
Iwamura, Masatsugu
キーワード: Urethral cancer
Chemotherapy
Radiation
Octogenarian
発行日: 31-Jul-2016
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 62
号: 7
開始ページ: 367
終了ページ: 371
抄録: We report two octogenarian patients with primary urethral cancer treated with chemotherapy and external beam radiation therapy. An 85-year-old female presented with perineal bleeding. Magnetic resonance imaging (MRI) showed a locally advanced tumor in the urethra. Biopsy was performed and pathologic findings demonstrated squamous cell carcinoma. After receiving one cycle of a half dose of gemcitabine and nedaplatin, the patient received external beam radiation therapy with gemcitabine and nedaplatin treatment followed by two more cycles of chemotherapy. Complete response was achieved. An 87-year-old female presented with vaginal bleeding. MRIrevealed locally advanced urethral tumor with bilateral inguinal lymph node metastases. Scratch and urine cytology of tumor demonstrated squamous cell carcinoma. After the same treatment as in case 1, primary cancer and lymph node metastases were significantly decreased. There have been no signs of recurrence or progression after treatment, and no severe adverse events in either patient during 53 and 26 months’follow up, respectively.
著作権等: 許諾条件により本文は2017/08/01に公開
DOI: 10.14989/ActaUrolJap_62_7_367
URI: http://hdl.handle.net/2433/216311
PubMed ID: 27569355
出現コレクション:Vol.62 No.7

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。